Adamis Pharmaceuticals Corporation Analysis
| Analyst Ratings |
|
Average Target Price
|
0.42
|
|
Average Rating
|
|
|
# Strong Buys
|
|
|
# Buys
|
|
|
# Holds
|
|
|
# Sells
|
|
|
# Strong Sells
|
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.03
|
-0.03
|
0.00
|
0.00%
|
|
2022-06-30
|
-0.04
|
-0.06
|
-0.02
|
-50.00%
|
|
2022-03-31
|
-0.03
|
-0.07
|
-0.04
|
-133.33%
|
|
2021-12-31
|
-0.04
|
-0.06
|
-0.02
|
-50.00%
|
|
2021-09-30
|
-0.04
|
-0.08
|
-0.04
|
-100.00%
|
|
2021-06-30
|
-0.06
|
-0.04
|
0.02
|
33.33%
|
|
2021-03-31
|
-0.06
|
-0.24
|
-0.18
|
-300.00%
|
|
2020-12-31
|
-0.06
|
-0.24
|
-0.18
|
-300.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.16
|
|
2021-12-31
|
-0.42
|
|
2020-12-31
|
-0.64
|
|
2019-12-31
|
-0.55
|
|
2018-12-31
|
-1.01
|
|
2017-12-31
|
-0.90
|
|
2016-12-31
|
-1.56
|
|
2015-12-31
|
-1.10
|
|
2014-12-31
|
-1.21
|
|
2013-12-31
|
-0.82
|
|
2012-12-31
|
-1.19
|
|
2011-12-31
|
-1.03
|
|
2010-12-31
|
-2.27
|
|
2009-12-31
|
-5.98
|
|
2007-12-31
|
-10.90
|
|
2006-12-31
|
33.88
|
|
2004-12-31
|
-219.62
|
|
2003-12-31
|
-114.98
|
|
2002-12-31
|
-145.16
|
|
2001-12-31
|
-168.79
|
|
2000-12-31
|
-116.47
|
|
1999-12-31
|
-138.40
|
|
1998-12-31
|
-136.72
|
|
1997-12-31
|
-52.33
|